HOMOMERIC AND HETEROMERIC RECEPTOR COMPLEX FORMATION OF BONE MORPHOGENETIC TYPE I RECEPTORS ALK2 AND ALK3

被引：0

作者：

Traeger, Lisa ^{[1
]}

Gallitz, Inka ^{[1
]}

Sekhri, Rohit ^{[1
]}

Baeumer, Nicole ^{[2
]}

Kuhlmann, Tanja ^{[3
]}

Kemming, Claudia ^{[3
]}

Bartnikas, Thomas B. ^{[4
]}

Steinbicker, Andrea U. ^{[1
]}

机构：

[1] Univ Hosp Muenster, Dept Anesthesiol Intens Care & Pain Med, Munster, Germany

[2] Univ Hosp Muenster, Dept Med Hematol & Oncol A, Munster, Germany

[3] Univ Hosp Muenster, Inst Neuropathol, Munster, Germany

[4] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2017年 / 92卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

207

引用

页码：E448 / E448

页数：1

共 50 条

[1] Hemojuvelin-mediated hepcidin induction requires both bone morphogenetic protein type I receptors ALK2 and ALK3
Dogan, Deniz Y.
Urzica, Eugen I.
Hornung, Isabelle
Kastl, Philipp
Oguama, David
Fette, Franca M.
Nguyen, Lien H.
Rosenbauer, Frank
Zacharowski, Kai
Klingmueller, Ursula
Gradhand, Elise
von Knethen, Andreas
Popp, Ruediger
Fleming, Ingrid
Schrader, Lisa
Steinbicker, Andrea U.
BLOOD ADVANCES, 2024, 8 (11) : 2870 - 2879
[2] ALK2 and ALK3 BMP Type I Receptors Are Required for the Development of Cardiac Hypertrophy
Shahid, Mohd
Spagnolli, Ester
Ernande, Laura
Kolodziej, Starsha
Mayeur, Claire
Leyton, Patricio
Scherrer-Crosbie, Marielle
Bloch, Kenneth D.
CIRCULATION, 2013, 128 (22)
[3] Mesenchyme-Specific Activation of BMP Receptor ALK2, but not ALK3, Results in Altered Tongue Formation and Cell Differentiation
Ishan, Mohamed
Chen, Guiqian
Patel, Sunny
Marshall, Brett
Mishina, Yuji
Liu, Hong-Xiang
CHEMICAL SENSES, 2018, 43 (04) : E42 - E42
[4] Inhibiting ALK2/ALK3 Signaling to Differentiate and Chemo-Sensitize Medulloblastoma
Filipponi, Doria
Pagnuzzi-Boncompagni, Marina
Pages, Gilles
CANCERS, 2022, 14 (09)
[5] Alk2/ACVR1 and Alk3/BMPR1A Provide Essential Function for Bone Morphogenetic Protein-Induced Retinal Angiogenesis
Lee, Heon-Woo
Chong, Diana C.
Ola, Roxana
Dunworth, William P.
Meadows, Stryder
Ka, Jun
Kaartinen, Vesa M.
Qyang, Yibing
Cleaver, Ondine
Bautch, Victoria L.
Eichmann, Anne
Jin, Suk-Won
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (04) : 657 - 663
[6] Development of a potent and ALK2 selective bone morphogenetic protein receptor (BMP) inhibitor
Hopkins, Corey R.
Engers, Darren W.
Frist, Audrey Y.
Lindsley, Craig W.
Hong, Charles H.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
[7] Structure of the Bone Morphogenetic Protein Receptor ALK2 and Implications for Fibrodysplasia Ossificans Progressiva
Chaikuad, Apirat
Alfano, Ivan
Kerr, Georgina
Sanvitale, Caroline E.
Boergermann, Jan H.
Triffitt, James T.
von Delft, Frank
Knapp, Stefan
Knaus, Petra
Bullock, Alex N.
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (44) : 36990 - 36998
[8] ALK3 undergoes ligand-independent homodimerization and BMP-induced heterodimerization with ALK2
Traeger, Lisa
Gallitz, Inka
Sekhri, Rohit
Baeumer, Nicole
Kuhlmann, Tanja
Kemming, Claudia
Holtkamp, Michael
Mueller, Jennifer-Christin
Karst, Uwe
Canonne-Hergaux, Francois
Muckenthaler, Martina U.
Bloch, Donald B.
Olschewski, Andrea
Bartnikas, Thomas B.
Steinbicker, Andrea U.
FREE RADICAL BIOLOGY AND MEDICINE, 2018, 129 : 127 - 137
[9] The BMP Type I Receptor Alk2 is a Key Regulator of Chondrogenesis
Culbert, Andria
Chakkalakal, Salin
Theosmy, Edwin
Wang, Linda
Shore, Eileen
JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
[10] INVESTIGATIONS OF ACTIVATED ACVR1/ALK2, A BONE MORPHOGENETIC PROTEIN TYPE I RECEPTOR, THAT CAUSES FIBRODYSPLASIA OSSIFICANS PROGRESSIVA
Kaplan, Frederick S.
Seemann, Petra
Haupt, Julia
Xu, Meiqi
Lounev, Vitali Y.
Mullins, Mary
Shore, Eileen M.
METHODS IN ENZYMOLOGY, VOLUME 484: CONSTITUTIVE ACTIVITY IN RECEPTORS AND OTHER PROTEINS, PART A, 2010, 484 : 357 - 373

← 1 2 3 4 5 →